Global Live Attenuated Vaccines Market Research Report 2017

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 118030

In this report, the global Live Attenuated Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Live Attenuated Vaccines in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Live Attenuated Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Companion Animals
Livestock Animals
Equine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Live Attenuated Vaccines for each application, including
Veterinary Clinics
Veterinary Hospitals
Others

Table of Contents

Global Live Attenuated Vaccines Market Research Report 2017
1 Live Attenuated Vaccines Market Overview
1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Live Attenuated Vaccines Segment by Type (Product Category)
1.2.1 Global Live Attenuated Vaccines Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Live Attenuated Vaccines Production Market Share by Type (Product Category) in 2016
1.2.3 Companion Animals
1.2.4 Livestock Animals
1.2.5 Equine
1.3 Global Live Attenuated Vaccines Segment by Application
1.3.1 Live Attenuated Vaccines Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Veterinary Clinics
1.3.3 Veterinary Hospitals
1.3.4 Others
1.4 Global Live Attenuated Vaccines Market by Region (2012-2022)
1.4.1 Global Live Attenuated Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Live Attenuated Vaccines (2012-2022)
1.5.1 Global Live Attenuated Vaccines Revenue Status and Outlook (2012-2022)
1.5.2 Global Live Attenuated Vaccines Capacity, Production Status and Outlook (2012-2022)

2 Global Live Attenuated Vaccines Market Competition by Manufacturers
2.1 Global Live Attenuated Vaccines Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Live Attenuated Vaccines Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Live Attenuated Vaccines Production and Share by Manufacturers (2012-2017)
2.2 Global Live Attenuated Vaccines Revenue and Share by Manufacturers (2012-2017)
2.3 Global Live Attenuated Vaccines Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Live Attenuated Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Live Attenuated Vaccines Market Competitive Situation and Trends
2.5.1 Live Attenuated Vaccines Market Concentration Rate
2.5.2 Live Attenuated Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Live Attenuated Vaccines Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Live Attenuated Vaccines Capacity and Market Share by Region (2012-2017)
3.2 Global Live Attenuated Vaccines Production and Market Share by Region (2012-2017)
3.3 Global Live Attenuated Vaccines Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Live Attenuated Vaccines Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Live Attenuated Vaccines Consumption by Region (2012-2017)
4.2 North America Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)
4.3 Europe Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)
4.4 China Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)
4.5 Japan Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)
4.7 India Live Attenuated Vaccines Production, Consumption, Export, Import (2012-2017)

5 Global Live Attenuated Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Live Attenuated Vaccines Production and Market Share by Type (2012-2017)
5.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global Live Attenuated Vaccines Price by Type (2012-2017)
5.4 Global Live Attenuated Vaccines Production Growth by Type (2012-2017)

6 Global Live Attenuated Vaccines Market Analysis by Application
6.1 Global Live Attenuated Vaccines Consumption and Market Share by Application (2012-2017)
6.2 Global Live Attenuated Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Live Attenuated Vaccines Manufacturers Profiles/Analysis
7.1 Merial
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Live Attenuated Vaccines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Merial Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 QYH Biotech
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Live Attenuated Vaccines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 QYH Biotech Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 DHN
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Live Attenuated Vaccines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 DHN Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 HVRI
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Live Attenuated Vaccines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 HVRI Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 CEVA
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Live Attenuated Vaccines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 CEVA Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Elanco
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Live Attenuated Vaccines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Elanco Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Yebio
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Live Attenuated Vaccines Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Yebio Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Zoetis
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Live Attenuated Vaccines Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Zoetis Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 FATRO
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Live Attenuated Vaccines Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 FATRO Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Kyoto Biken
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Live Attenuated Vaccines Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Kyoto Biken Live Attenuated Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 CAVAC
7.12 Ringpu Biology
7.13 Vaksindo
7.14 ChengDu Tecbond
7.15 Sindh Poultry Vaccine Centre
7.16 Merck Animal Health

8 Live Attenuated Vaccines Manufacturing Cost Analysis
8.1 Live Attenuated Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Live Attenuated Vaccines

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Live Attenuated Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Live Attenuated Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Live Attenuated Vaccines Market Forecast (2017-2022)
12.1 Global Live Attenuated Vaccines Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Live Attenuated Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Live Attenuated Vaccines Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Live Attenuated Vaccines Price and Trend Forecast (2017-2022)
12.2 Global Live Attenuated Vaccines Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Live Attenuated Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Live Attenuated Vaccines Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Live Attenuated Vaccines Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer